Core Viewpoint - Nanjing New Pharmaceutical has experienced a significant stock price increase following the announcement of plans to acquire a domestic pharmaceutical technology asset group, although it remains uncertain if this constitutes a major asset restructuring [2][18]. Stock Performance - On July 29 and 30, Nanjing New Pharmaceutical's stock price surged, reaching a closing price of 14.28 yuan per share, marking a 20% increase and a total market capitalization of 3.918 billion yuan [4][12]. - The stock's price deviation over three trading days from July 28 to July 30 reached a cumulative increase of 30%, qualifying as an abnormal trading fluctuation under Shanghai Stock Exchange regulations [8][18]. - On July 29, the stock saw a late surge, closing with a 17.01% increase, while on July 30, it hit the daily limit with a 20% increase [10][12]. Institutional Investment - During the price surge, Nanjing New Pharmaceutical appeared on the "Dragon and Tiger List," indicating significant buying activity from institutional accounts, with the top five buying and selling accounts being institutional [7][15]. Financial Performance - Nanjing New Pharmaceutical has faced declining financial performance, with net profits for the years 2022 to 2024 reported as -78.83 million yuan, -10.87 million yuan, and -357 million yuan respectively, indicating a trend of increasing losses [18][20]. - In the first quarter of 2025, the company reported a year-on-year decline in operating revenue, net profit attributable to shareholders, and net profit after deducting non-recurring gains and losses of 70.21%, 143.66%, and 146.27% respectively [20].

Group 1: Company Performance - Ningde Times reported a net profit of 30.5 billion yuan for the first half of the year, representing a year-on-year increase of 33.02% [1] - The company achieved revenue of 178.9 billion yuan, an increase of 7.27% compared to the same period last year [1] - Gross profit reached 44.8 billion yuan, up 14.45% year-on-year, with a gross margin of 25.02%, an increase of 1.57 percentage points from the previous year [1] Group 2: Stock Trading and Suspensions - Shangwei New Materials announced a suspension of trading due to multiple instances of abnormal stock price fluctuations, with the suspension expected to last no more than three trading days [2] - Jinchengzi is planning to acquire 55% of Samit Optoelectronics, leading to a stock suspension for up to ten trading days [3] - Sanchao New Materials is also planning a change in control, resulting in a stock suspension for up to two trading days [6] - Hehua Co. announced a stock suspension due to potential changes in its controlling shareholder [9] Group 3: Major Investments and Projects - Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project [5] - The company will use its own funds for this investment, with the final amount to be confirmed based on state-approved preliminary design estimates [5] Group 4: Other Corporate Actions - Sunshine Dairy's controlling shareholder sold a total of 1.1452 million shares, accounting for 0.41% of the company's total share capital, without triggering any significant changes in control [4] - Nanjing Pharmaceutical is in the process of planning the acquisition of a domestic pharmaceutical technology asset group, with uncertainty regarding whether it constitutes a major asset restructuring [7]

智通财经7月30日晚间新闻精选 3、百亿湖北人形机器人母基金启动，首期50亿落地，前瞻布局机器人"大脑"和"小脑"及"肢体"等领 域。 1、中共中央政治局召开会议，决定召开二十届四中全会，分析研究当前经济形势和经济工作。会议指 出，宏观政策要持续发力、适时加力；增强国内资本市场的吸引力和包容性，巩固资本市场回稳向好势 头。 2、中央财政今年初步安排预算900亿元育儿补贴，各地将在8月下旬陆续开放育儿补贴申领。 4、广期所调整工业硅、多晶硅、碳酸锂期货部分合约交易限额，部分合约单日开仓量不得超过500手。 5、宁德时代上半年实现净利润305亿元 同比增长33.02%。上纬新材：多次触及股票交易异常波动和严 重异常波动情形 明起停牌核查。南新制药：近期正筹划购买某一国内药品技术等资产组事项 尚无法确 定是否构成重大资产重组。20CM五天四板幸福蓝海：公司是《南京照相馆》的投资方之一 投资比例较 低。2连板阳光乳业：公司控股股东近两日合计卖出114.52万股。 ...

（原标题：7月30日重要资讯一览） 重要的消息有哪些 1．中共中央政治局7月30日召开会议，会议指出，要持续防范化解重点领域风险。落实好中央城市工作会议精神，高质量开展城市更新。积极稳 妥化解地方政府债务风险，严禁新增隐性债务，有力有序有效推进地方融资平台出清。增强国内资本市场的吸引力和包容性，巩固资本市场回稳 向好势头。 2．财政部社会保障司司长郭阳7月30日在国新办新闻发布会上表示，中央财政将设立共同财政事权转移支付项目"育儿补贴补助资金"，今年初步 安排预算900亿元左右。对于发放国家基础标准补贴所需资金，中央财政按照一定比例对地方予以补助，中央财政总体承担90%。 3．7月30日，外交部发言人郭嘉昆主持例行记者会。在回答有关中美经贸会谈的问题时，郭嘉昆表示，关于此次中美经贸会谈的情况，中方已经 发布了消息。我们希望美方同中方一道，按照两国元首通话达成的重要共识，发挥好中美经贸磋商机制的作用，在平等、尊重、互惠基础上，通 过对话沟通，增进共识、减少误解、加强合作，争取更多双赢成果，共同推动中美关系健康稳定可持续发展。 4．国家发改委向社会公开征求《政府投资基金布局规划和投向工作指引》和《加强政府投资基金 ...

Important Announcements - Company Shouwei New Materials will suspend trading for inspection on July 31, 2025, due to abnormal stock price fluctuations from July 9 to July 30, 2025 [2] - Company XGIMI Technology expects a net profit attributable to shareholders of 88.66 million yuan for the first half of the year, a year-on-year increase of 2062.33% [4] - Company Yuntian Lifei has submitted an application for H-share issuance and listing [5] - Company Huaheng Biological is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Company Hehua Co., Ltd. is planning a change in control, leading to a suspension of trading [10] Financial Performance - Company Dingtong Technology reported a net profit of 115 million yuan for the first half of the year, a year-on-year increase of 134.06%, with a proposed cash dividend of 2 yuan per 10 shares [7] - Company Jinhai Biological achieved a net profit of 138 million yuan in the first half of the year, a year-on-year increase of 51.52% [13] - Company Hisense Home Appliances reported a net profit of 2.077 billion yuan for the first half of the year, a year-on-year increase of 3.01% [14] Corporate Actions - Company Nanxin Pharmaceutical is planning to acquire a domestic pharmaceutical technology asset group, but there is significant uncertainty regarding the completion of this acquisition [3] - Company Jinchengzi is planning to acquire 55% of the shares of Changchun Samit Optoelectronics Technology Co., Ltd., leading to a suspension of trading [9] - Company San Chao New Materials is also planning a change in control, resulting in a trading suspension [11] Project Investments - Company Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project [8]

Group 1: Company Announcements - Upwind New Materials will suspend trading for stock review starting July 31, 2025, due to abnormal price fluctuations from July 9 to July 30, 2025 [2] - XGIMI Technology expects a net profit attributable to shareholders of 88.66 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [4] - CloudWalk Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [5] - Huaheng Biological is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Hehua Co., Ltd. is undergoing a control change process, leading to a stock suspension starting July 31, 2025 [9] Group 2: Financial Performance - DingTong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06%, with a proposed cash dividend of 2 yuan per 10 shares [7] - Jinhe Biological achieved a net profit of 138 million yuan in the first half of 2025, a year-on-year increase of 51.52% [12] - Hisense Home Appliances reported a net profit of 2.077 billion yuan for the first half of 2025, a year-on-year increase of 3.01% [13] Group 3: Corporate Developments - Nanxin Pharmaceutical is planning to acquire a domestic pharmaceutical technology asset group, but there is significant uncertainty regarding the completion of this acquisition [3] - Jinchengzi is planning to acquire 55% of the equity of Changchun Samit Optoelectronics Technology Co., Ltd., leading to a stock suspension starting July 31, 2025 [8] - SanChao New Materials is also planning a control change, resulting in a stock suspension starting July 31, 2025 [10] Group 4: Industry Developments - Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project, with a total construction period of 91 months [8] - Yonghui Supermarket intends to raise no more than 3.992 billion yuan through a private placement to upgrade stores and logistics [8]

Group 1 - Company Shenzhou New Materials has experienced multiple instances of abnormal stock trading fluctuations and will be suspended from trading starting July 31, 2025, for up to three trading days [1] - The stock price of Shenzhou New Materials has increased over 1288% this year, making it the first tenfold stock of 2025 [1] - Company Yangtze Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba shipping capacity expansion project, with funding sourced from its own funds [2] - Yonghui Supermarket intends to raise no more than 3.992 billion yuan through a private placement of A-shares for store upgrades and logistics improvements [3] Group 2 - Chipsea Technology is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy and competitiveness [4] - Zhongwang Software is facing a copyright infringement lawsuit from Autodesk in a California federal court, with the amount in dispute yet to be determined [5] - Jinchengzi is planning to acquire 55% of the equity of Changchun Samit Optoelectronics Technology Co., Ltd., and will suspend trading starting July 31, 2025, for up to ten trading days [6] - Nanxin Pharmaceutical is in the process of planning the acquisition of a domestic pharmaceutical technology asset group, with significant uncertainty regarding whether it constitutes a major asset restructuring [7] Group 3 - Huaheng Biological is preparing to issue H-shares and list on the Hong Kong Stock Exchange to advance its global strategy [9] - Sanchao New Materials is planning a change in company control and will suspend trading starting July 31, 2025, for up to two trading days [10] - Digital Certification's controlling shareholder will change to Beijing Data Group following a transfer of state-owned shares [11] - Hongxiang Co., Ltd.'s actual controller has been placed under residential surveillance, but this will not affect the company's normal operations [12]

公告显示，南新制药股票交易连续三个交易日内（7月28日—30日）收盘价格涨幅偏离值累计达到 30%，根据《上海证券交易所交易规则》《上海证券交易所科创板股票异常交易实时监控细则》的有关 规定，属于股票交易异常波动的情形。7月30日，南新制药收涨20%，收盘价为14.28元/股。 北京商报讯（记者 丁宁）7月30日晚间，南新制药（688189）发布公告称，公司近期正在筹划购买某一 国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签署任 何有关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据该事项的进展情况及时履行 信息披露义务，具体内容以公司后续公告为准。 ...

7月30日南新制药(688189)收盘价14.28元，收盘涨停，全天换手率18.41%，振幅20.00%，成交额6.93亿 元。科创板交易公开信息显示，当日该股因日收盘价涨幅达15%等上榜。 南新制药7月30日龙虎榜 | 买入营业部名称 | 买入金额(万元) | | --- | --- | | 国泰海通证券股份有限公司总部 | 1943.58 | | 中信建投证券股份有限公司北京朝阳分公司 | 1637.53 | | 华泰证券股份有限公司总部 | 1519.17 | | 华鑫证券有限责任公司绍兴胜利东路证券营业部 | 1319.76 | | 中国中金财富证券有限公司杭州江河汇证券营业部 | 1234.99 | | 卖出营业部名称 | 卖出金额(万元) | | 国泰海通证券股份有限公司总部 | 1878.45 | | 东方财富证券股份有限公司上海东方路证券营业部 | 1253.83 | | 机构专用 | 1096.71 | | 瑞银证券有限责任公司上海花园石桥路证券营业部 | 1000.09 | | 国金证券股份有限公司上海静安区南京西路证券营业部 | 936.91 | 证券时报·数据宝统计显示，上榜的前五大买 ...

每经AI快讯，有投资者在投资者互动平台提问：公司有什么产品可以用于治疗基孔肯雅热病症吗？ 南新制药（688189.SH）7月30日在投资者互动平台表示，公司暂未生产和销售治疗该病症的药品。 （文章来源：每日经济新闻） ...